Search alternatives:
point decrease » point increase (Expand Search)
non decrease » nn decrease (Expand Search), note decreased (Expand Search), fold decrease (Expand Search)
a decrease » _ decrease (Expand Search), _ decreased (Expand Search), _ decreases (Expand Search)
point decrease » point increase (Expand Search)
non decrease » nn decrease (Expand Search), note decreased (Expand Search), fold decrease (Expand Search)
a decrease » _ decrease (Expand Search), _ decreased (Expand Search), _ decreases (Expand Search)
-
67941
Table2_Fire, volcanism and climate change: the main factors controlling mercury (Hg) accumulation rates in Tropical Lake Lantoa, Sulawesi, Indonesia (∼16,500–540 cal yr BP).xlsx...
Published 2023“…The Holocene Transition was marked by a decrease in HgAR (µ = 8, 3.50–18.84 μg m<sup>−2</sup> yr<sup>−1</sup>) as humid conditions precluded forest burning, followed by high HgAR (µ = 11.35, 3.30–158.32 μg m<sup>−2</sup> yr<sup>−1</sup>) in the Early Holocene. …”
-
67942
Table1_Fire, volcanism and climate change: the main factors controlling mercury (Hg) accumulation rates in Tropical Lake Lantoa, Sulawesi, Indonesia (∼16,500–540 cal yr BP).xlsx...
Published 2023“…The Holocene Transition was marked by a decrease in HgAR (µ = 8, 3.50–18.84 μg m<sup>−2</sup> yr<sup>−1</sup>) as humid conditions precluded forest burning, followed by high HgAR (µ = 11.35, 3.30–158.32 μg m<sup>−2</sup> yr<sup>−1</sup>) in the Early Holocene. …”
-
67943
Table3_Fire, volcanism and climate change: the main factors controlling mercury (Hg) accumulation rates in Tropical Lake Lantoa, Sulawesi, Indonesia (∼16,500–540 cal yr BP).xlsx...
Published 2023“…The Holocene Transition was marked by a decrease in HgAR (µ = 8, 3.50–18.84 μg m<sup>−2</sup> yr<sup>−1</sup>) as humid conditions precluded forest burning, followed by high HgAR (µ = 11.35, 3.30–158.32 μg m<sup>−2</sup> yr<sup>−1</sup>) in the Early Holocene. …”
-
67944
Table4_Fire, volcanism and climate change: the main factors controlling mercury (Hg) accumulation rates in Tropical Lake Lantoa, Sulawesi, Indonesia (∼16,500–540 cal yr BP).xlsx...
Published 2023“…The Holocene Transition was marked by a decrease in HgAR (µ = 8, 3.50–18.84 μg m<sup>−2</sup> yr<sup>−1</sup>) as humid conditions precluded forest burning, followed by high HgAR (µ = 11.35, 3.30–158.32 μg m<sup>−2</sup> yr<sup>−1</sup>) in the Early Holocene. …”
-
67945
Table_1_Long-Term Cardiac Safety and Survival Outcomes of Neoadjuvant Pegylated Liposomal Doxorubicin in Elderly Patients or Prone to Cardiotoxicity and Triple Negative Breast Canc...
Published 2021“…Most of tumors (88%) were triple negative. No significant decreases in LVEF were observed. The mean baseline LVEF was 66.6% (52-86) and after a median follow-up of 5 years, mean LVEF was 66 (54.5-73). …”
-
67946
DataSheet_2_Long-Term Cardiac Safety and Survival Outcomes of Neoadjuvant Pegylated Liposomal Doxorubicin in Elderly Patients or Prone to Cardiotoxicity and Triple Negative Breast...
Published 2021“…Most of tumors (88%) were triple negative. No significant decreases in LVEF were observed. The mean baseline LVEF was 66.6% (52-86) and after a median follow-up of 5 years, mean LVEF was 66 (54.5-73). …”
-
67947
Table_1_Long-Term Cardiac Safety and Survival Outcomes of Neoadjuvant Pegylated Liposomal Doxorubicin in Elderly Patients or Prone to Cardiotoxicity and Triple Negative Breast Canc...
Published 2021“…Most of tumors (88%) were triple negative. No significant decreases in LVEF were observed. The mean baseline LVEF was 66.6% (52-86) and after a median follow-up of 5 years, mean LVEF was 66 (54.5-73). …”
-
67948
Table_2_Long-Term Cardiac Safety and Survival Outcomes of Neoadjuvant Pegylated Liposomal Doxorubicin in Elderly Patients or Prone to Cardiotoxicity and Triple Negative Breast Canc...
Published 2021“…Most of tumors (88%) were triple negative. No significant decreases in LVEF were observed. The mean baseline LVEF was 66.6% (52-86) and after a median follow-up of 5 years, mean LVEF was 66 (54.5-73). …”
-
67949
DataSheet_2_Long-Term Cardiac Safety and Survival Outcomes of Neoadjuvant Pegylated Liposomal Doxorubicin in Elderly Patients or Prone to Cardiotoxicity and Triple Negative Breast...
Published 2021“…Most of tumors (88%) were triple negative. No significant decreases in LVEF were observed. The mean baseline LVEF was 66.6% (52-86) and after a median follow-up of 5 years, mean LVEF was 66 (54.5-73). …”
-
67950
Table_3_Long-Term Cardiac Safety and Survival Outcomes of Neoadjuvant Pegylated Liposomal Doxorubicin in Elderly Patients or Prone to Cardiotoxicity and Triple Negative Breast Canc...
Published 2021“…Most of tumors (88%) were triple negative. No significant decreases in LVEF were observed. The mean baseline LVEF was 66.6% (52-86) and after a median follow-up of 5 years, mean LVEF was 66 (54.5-73). …”
-
67951
Table_3_Long-Term Cardiac Safety and Survival Outcomes of Neoadjuvant Pegylated Liposomal Doxorubicin in Elderly Patients or Prone to Cardiotoxicity and Triple Negative Breast Canc...
Published 2021“…Most of tumors (88%) were triple negative. No significant decreases in LVEF were observed. The mean baseline LVEF was 66.6% (52-86) and after a median follow-up of 5 years, mean LVEF was 66 (54.5-73). …”
-
67952
DataSheet_1_Long-Term Cardiac Safety and Survival Outcomes of Neoadjuvant Pegylated Liposomal Doxorubicin in Elderly Patients or Prone to Cardiotoxicity and Triple Negative Breast...
Published 2021“…Most of tumors (88%) were triple negative. No significant decreases in LVEF were observed. The mean baseline LVEF was 66.6% (52-86) and after a median follow-up of 5 years, mean LVEF was 66 (54.5-73). …”
-
67953
Table_2_Long-Term Cardiac Safety and Survival Outcomes of Neoadjuvant Pegylated Liposomal Doxorubicin in Elderly Patients or Prone to Cardiotoxicity and Triple Negative Breast Canc...
Published 2021“…Most of tumors (88%) were triple negative. No significant decreases in LVEF were observed. The mean baseline LVEF was 66.6% (52-86) and after a median follow-up of 5 years, mean LVEF was 66 (54.5-73). …”
-
67954
DataSheet_1_Long-Term Cardiac Safety and Survival Outcomes of Neoadjuvant Pegylated Liposomal Doxorubicin in Elderly Patients or Prone to Cardiotoxicity and Triple Negative Breast...
Published 2021“…Most of tumors (88%) were triple negative. No significant decreases in LVEF were observed. The mean baseline LVEF was 66.6% (52-86) and after a median follow-up of 5 years, mean LVEF was 66 (54.5-73). …”
-
67955
Impairment of RPA foci formation and the DNA damage checkpoint in CBP and p300 depleted cells.
Published 2012“…(<b>D, E</b>) Decreased DNA damage-induced chromatin binding of RPA proteins in H1299 cells. …”
-
67956
Breadth and magnitude of CD8<sup>+</sup> T-cell IFN-γ responses to clade-B consensus and autologous HIV-1 Nef peptides.
Published 2012“…The negative control = non-stimulated, positive control tube = (SEB) used <i>Staphylococcus aureus</i> Enterotoxin B superantigen as stimulant. …”
-
67957
-
67958
Data Sheet 1_Prevalence of fungal colonization among patients with psoriasis in difficult-to-treat areas: impact of apremilast on mycotic burden and clinical outcomes.pdf
Published 2024“…Finally, improvements in clinical scores i.e., PASI, NAPSI, DLQI, itch VAS, PAIN VAS, scPGA and sPGA-G and biochemical serum profile, as well as a significant decrease in serum IL-17A, TGF-β 1 and IL-10 levels (from 8.51 to 4.16 pg/mL; from 66.10 to 48.70 ng/mL and from 20.05 to 14 pg/mL, respectively) were observed in all patients.…”
-
67959
-
67960